Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia
NCT ID: NCT02787122
Last Updated: 2020-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2014-01-01
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial of Cognitive Behavioral Therapy for Schizophrenia
NCT00300651
Cognitive Training for Emotion Regulation in Psychotic Disorders
NCT04414215
Psychological Intervention for Relapse Prevention in First Episode Schizophrenia
NCT00161408
Evaluation of Internet-based Cognitive Behavioral Self-help Treatments for People With Psychosis
NCT02974400
Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis
NCT00465920
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Thus, the aim of the present single-blind randomized-controlled pilot therapy study was to assess the efficacy of a new form of emotion-focussed Cognitive behavior therapy for psychosis with regard to change in positive symptoms and delusions in comparison to standard treatment.
The main hypotheses are:
\- Efficacy of CBT-E: patients with schizophrenia who receive CBT-E show a more pronounced reduction of delusions (primary outcome), as well as a more pronounced reduction of positive symptoms, depression and general psychopathology, a stronger improvement in general and social functioning and will receive lower doses of antipsychotic medication (secondary outcomes) at post-treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CBT-E
Emotion-focussed Cognitive behavior therapy:
Patients receive 25 sessions of individual emotion-focused Cognitive Behavior Therapy. Interventions are behavioral activation, training of emotion regulation strategies, improvement of self-esteem and relapse prevention.
CBT-E
Patients receive 25 sessions of individual emotion-focused Cognitive Behavior Therapy based on a manual. Interventions aim on patients' mood by implementing positive activities in their daily routine. Further, patients train to reduce worrying behavior. Social contacts are fostered as well. Later, patients are informed on emotions and train emotion regulation strategies. Finally, the focus of CBT-E is on self-acceptance.Patients receive psychoeducation on self-acceptance and learn strategies in order to reduce negative self-schema and foster positive self-schema.
Treatment as Usual
Patients who are randomized and assigned to the Wait list are required to wait for half a year, while they receive standardized care (antipsychotic medication). After half a year, they receive CBT-E, as well.
Treatment as Usual
Patients receive standardized treatment. After a waiting period of six month, patients receive CBT-E
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBT-E
Patients receive 25 sessions of individual emotion-focused Cognitive Behavior Therapy based on a manual. Interventions aim on patients' mood by implementing positive activities in their daily routine. Further, patients train to reduce worrying behavior. Social contacts are fostered as well. Later, patients are informed on emotions and train emotion regulation strategies. Finally, the focus of CBT-E is on self-acceptance.Patients receive psychoeducation on self-acceptance and learn strategies in order to reduce negative self-schema and foster positive self-schema.
Treatment as Usual
Patients receive standardized treatment. After a waiting period of six month, patients receive CBT-E
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Positive and Negative Syndrome Scale score in item P1 (delusions) of at least two
* fluent in German language
* agree to participate
* estimated general intelligence of at least 70 (assessed with the German Wortschatztest (MWT-B)
* no present suicidality
Exclusion Criteria
* comorbid diagnosis of borderline personality disorder and/or substance use disorder in the last six month
* intake of Benzodiazepines
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Hamburg-Eppendorf
OTHER
Philipps University Marburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Stephanie Mehl
Prof. Dr. rer. nat.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephanie Mehl, Ph. D.
Role: PRINCIPAL_INVESTIGATOR
Philipps University Marburg
Tania M. Lincoln
Role: PRINCIPAL_INVESTIGATOR
University of Hamburg-Eppendorf
Winfried Rief
Role: STUDY_DIRECTOR
Philipps University Marburg
Tilo Kircher
Role: STUDY_DIRECTOR
Philipps University Marburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Marburg, Faculty of Clinical Psychology and Psychotherapy
Marburg, Hesse, Germany
University of Hamburg, Faculty of Clinical Psychology and Psychotherapy
Hamburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CBT-E_MehlLincoln
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.